Advances in phage therapy for <i>Acinetobacter baumannii</i>: mechanisms and applications. [PDF]
Cheng S +6 more
europepmc +1 more source
Antimicrobial Activity of LysX and LysP Endolysins Against <i>Pseudomonas syringae</i> pv. <i>syringae</i> and <i>Xanthomonas arboricola</i> pv. <i>juglandis</i>. [PDF]
Díaz B +10 more
europepmc +1 more source
Computational insights into the natural phage endolysin linker landscape. [PDF]
Cremelie E +3 more
europepmc +1 more source
Endolysin LysSte134_1 Reduces Staphylococcus Bacterial Load in Infected Wounds In Vivo. [PDF]
Golosova NN +6 more
europepmc +1 more source
PhaLP 2.0: extending the community-oriented phage lysin database with a SUBLYME pipeline for metagenomic discovery. [PDF]
Boulay A +8 more
europepmc +1 more source
Enhancing the Antibacterial Activity of Endolysin against <i>Klebsiella pneumoniae</i> through Fusion Engineering Using Antimicrobial Peptide Sub5. [PDF]
Gao K +11 more
europepmc +1 more source
Phages as antimicrobials against multi-drug resistant bacteria. [PDF]
Plat S, LaPointe G, Goodridge L.
europepmc +1 more source
Design Strategies for Positively Charged Endolysins: Insights Into Artilysin Development [PDF]
Altres ajuts: acords transformatius de la UABEndolysins are bacteriophage-encoded enzymes that can specifically degrade the peptidoglycan layer of bacterial cell wall, making them an attractive tool for the development of novel antibacterial agents.
José Vicente Carratala +2 more
exaly +4 more sources
Characterization of Five Novel Endolysins From Gram-Negative Infecting Bacteriophages
We here characterize five globular endolysins, encoded by a set of Gram-negative infecting bacteriophages: BcepC6gp22 (Burkholderia cepacia phage BcepC6B), P2gp09 (Escherichia coli phage P2), PsP3gp10 (Salmonella enterica phage PsP3), K11gp3.5 and ...
Rob Lavigne +2 more
exaly +2 more sources

